I can't believe they let the trial run with 22/23
Post# of 148187
But I do have some questions
How is the power calculated and what value is needed? All things being equal, how does the power change from 70% at 50% interim to 75% interim?
But most importantly, upon what authority can the DSMC authorize another interim analysis? Do they just do an interim analysis whenever they want? I thought that interim analyses and to be agreed upon with the FDA before the trial begins.